skip to main content

Neuroleptic Malignant Syndrome: An Intensive Care Unit Case of Exceptionally High Creatinine Kinase and Myoglobin Levels

Macedo, Eduardo ; Rodrigues, Filipa ; Marques, Ana Rita ; Ribeiro, Luís ; Silveira, Pedro

Cureus, 2024, Vol.16 (3), p.e56306-e56306

Texto completo disponível

Citações Citado por
  • Título:
    Neuroleptic Malignant Syndrome: An Intensive Care Unit Case of Exceptionally High Creatinine Kinase and Myoglobin Levels
  • Autor: Macedo, Eduardo ; Rodrigues, Filipa ; Marques, Ana Rita ; Ribeiro, Luís ; Silveira, Pedro
  • É parte de: Cureus, 2024, Vol.16 (3), p.e56306-e56306
  • Notas: ObjectType-Case Study-2
    content type line 59
    SourceType-Reports-1
    ObjectType-Report-1
  • Descrição: Neuroleptic Malignant Syndrome (NMS) is a rare, life-threatening neurologic emergency known to be related to the administration or sudden withdrawal of dopaminergic medications. The clinical course, symptoms, and bloodwork are very heterogeneous, making this syndrome difficult to identify. Thus, NMS is a diagnosis of exclusion. We present a case of severe NMS with exceptionally high creatinine kinase (CK) and myoglobin levels with unclear etiology and a challenging differential diagnosis. Also, our case stands out because it was serious, unique, and had a favorable outcome, which could contribute to the management of future similar cases.
  • Idioma: Inglês

Buscando em bases de dados remotas. Favor aguardar.